{"id":"tp-39844","type":"article-newspaper","title":"Genmab’s Rina-S Meets Phase 3 Survival Goals in Ovarian Cancer Trial","author":"John Kim","publisher":"TOKENPOST Inc.","url":"https://www.tokenpost.com/news/business/39844","datePublished":"2026-10-24T10:01:40.000Z","dateModified":"2026-10-24T10:01:40.000Z","language":"en","abstract":"The trial showed significant results for both progression-free and overall survival. Genmab plans to discuss next steps with regulators; its shares rose 9.48% at the Oct. 23 close.","section":"Business","references":[{"title":"earlier coverage of Rina-S combination safety results","url":"https://www.tokenpost.com/news/business/21312"}]}